Shanghai Labway Clinical Laboratory Co

Shanghai Labway Clinical Laboratory Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shanghai Labway Clinical Laboratory Co (301060.SZ) as of Nov 2, 2026 is 29.56 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -22.78 M CNY — a change of -229.75% (higher).

EBITDA

29.56 MCNY

YoY

-229.75%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shanghai Labway Clinical Laboratory Co is 2025 29.56 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shanghai Labway Clinical Laboratory Co was 2024 -22.78 M CNY. It decreases by -229.75% higher compared to the previous year.

The Shanghai Labway Clinical Laboratory Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
126.48 M CNY
Jan 1, 2019
145.18 M CNY
Jan 1, 2020
192.39 M CNY
Jan 1, 2021
343.81 M CNY
Jan 1, 2022
977.94 M CNY
Jan 1, 2023
-115.84 M CNY
Jan 1, 2024
-22.78 M CNY
Jan 1, 2025
29.56 M CNY
The Shanghai Labway Clinical Laboratory Co EBITDA history
YEAREBITDAYoY
29.56 MCNY-229.75%
-22.78 MCNY-80.33%
-115.84 MCNY-111.85%
977.94 MCNY+184.44%
343.81 MCNY+78.71%
192.39 MCNY+32.51%
145.18 MCNY+14.79%
126.48 MCNY+1,671.70%
7.14 MCNY-91.20%
81.14 MCNY-21.82%
103.79 MCNY+18.12%
87.87 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Labway Clinical Laboratory Co Stock analysis

What does Shanghai Labway Clinical Laboratory Co do? Shanghai Labway Clinical Laboratory Co., Ltd. generates revenue through medical and pathological examination services, including pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination, and physical and chemical examination. The company also sells in vitro diagnostic instruments, reagents, and related accessories and consumables. Its primary customers are healthcare providers and medical institutions requiring diagnostic services and diagnostic products. The business segments are medical testing services and in vitro diagnostic product sales. The company's medical testing services cater to hospitals and clinics seeking comprehensive diagnostic solutions, while the in vitro diagnostic product sales target healthcare facilities needing equipment and supplies for laboratory operations. These services and products are provided to clients across China, focusing on the healthcare sector's demand for accurate and timely diagnostic capabilities. Shanghai Labway's revenue streams are derived from both service fees for examinations and sales of diagnostic instruments and reagents. The company's offerings align with the growing need for advanced medical diagnostics in China's expanding healthcare market, serving a broad client base within the medical industry. Shanghai Labway Clinical Laboratory Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Labway Clinical Laboratory Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shanghai Labway Clinical Laboratory Co is 29.56 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shanghai Labway Clinical Laboratory Co changed from -22.78 M CNY to 29.56 M CNY, representing a -229.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Shanghai Labway Clinical Laboratory Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Shanghai Labway Clinical Laboratory Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Shanghai Labway Clinical Laboratory Co

All Key Metrics — Shanghai Labway Clinical Laboratory Co